CSIMarket
 
Fresenius Medical Care Ag  (NYSE: FMS)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Fresenius Medical Care Ag's Customers Performance

FMS



 
FMS's Source of Revenues Fresenius Medical Care Ag's Corporate Customers have recorded an increase in their cost of revenue by 10.11 % in the 4 quarter 2025 year on year, sequentially costs of revenue grew by 4.44 %. During the corresponding time, Fresenius Medical Care Ag recorded a revenue increase by 8.77 % year on year, sequentially revenue grew by 3.5 %. While revenue at the Fresenius Medical Care Ag's corporate clients recorded rose by 13.13 % year on year, sequentially revenue grew by 3.48 %.

List of FMS Customers




Fresenius Medical Care Ag's Customers have recorded an increase in their cost of revenue by 10.11 % in the 4 quarter 2025 year on year, sequentially costs of revenue grew by 4.44 %, for the same period Fresenius Medical Care Ag recorded revenue increase by 8.77 % year on year, sequentially revenue grew by 3.5 %.

List of FMS Customers

Fresenius Medical Care Ag's Business Units
Healthcare services    66.73 % of total Revenue
Healthcare products    22.49 % of total Revenue
Insurance contracts    10.78 % of total Revenue
Inter-eliminations    -9.33 % of total Revenue
Care Delivery    69.98 % of total Revenue
Care Delivery Segments    69.98 % of total Revenue
Care Delivery Inter-eliminations    -2.54 % of total Revenue
Care Delivery United States Segments    58.62 % of total Revenue
Care Delivery International Segments    11.36 % of total Revenue
Value-Based Care    11.45 % of total Revenue
Value-Based Care Segments    11.45 % of total Revenue
Care Enablement    27.9 % of total Revenue
Care Enablement Segments    27.9 % of total Revenue
Care Enablement Inter-eliminations    -6.8 % of total Revenue
Total Segment    109.33 % of total Revenue
Total Healthcare services    66.73 % of total Revenue
Total Healthcare products    22.04 % of total Revenue
Care Delivery Healthcare services    66.06 % of total Revenue
Care Delivery Healthcare products    1.38 % of total Revenue
Value-Based Care Healthcare services    0.67 % of total Revenue
Care Enablement Healthcare products    20.65 % of total Revenue
Corporate    -0.02 % of total Revenue
Inter-segment    9.35 % of total Revenue
Inter-Total Segment    -9.33 % of total Revenue
Inter-Care Delivery    -2.54 % of total Revenue
Inter-Care Enablement    -6.8 % of total Revenue
Germany    2.52 % of total Revenue
Rest of the World    97.48 % of total Revenue
United States    72.25 % of total Revenue




   
Customers Net Income fell in Q4 by Customers Net margin fell to %
-53.84 % 1.68 %
Customers Net Income fell in Q4 by -53.84 %


Customers Net margin fell to 1.68 % 1.68 %



Fresenius Medical Care Ag's Customers, Q4 2025 Revenue Growth By Industry
Customers in Accident & Health Insurance Industry      11.72 %
Customers in Life Insurance Industry      27.58 %
Customers in Property & Casualty Insurance Industry      27.75 %
Customers in Investment Services Industry      67.78 %
Customers in Miscellaneous Financial Services Industry      4.68 %
Customers in Healthcare Facilities Industry      8.97 %
     
• Customers Valuation • Customers Mgmt. Effect.


Fresenius Medical Care Ag's Comment on Sales, Marketing and Customers



The company operates in markets related to renal dialysis clinics and service businesses across multiple countries. Its renal dialysis clinic facilities are located in Brazil, Kazakhstan, and Malaysia. Service businesses are present in Chile, Ecuador, Sub-Saharan Africa, Türkiye, Guatemala, Curacao, Peru, Colombia, and the Cura Day Hospitals Group in Australia. These divestitures are part of the Legacy Portfolio Optimization plan aimed at concentrating on core business areas with higher profitable growth.





Fresenius Medical Care Ag’s Comment on Sales, Marketing and Customers


The company operates in markets related to renal dialysis clinics and service businesses across multiple countries. Its renal dialysis clinic facilities are located in Brazil, Kazakhstan, and Malaysia. Service businesses are present in Chile, Ecuador, Sub-Saharan Africa, Türkiye, Guatemala, Curacao, Peru, Colombia, and the Cura Day Hospitals Group in Australia. These divestitures are part of the Legacy Portfolio Optimization plan aimed at concentrating on core business areas with higher profitable growth.








FMS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Fresenius Medical Care Ag 13,196.76 21,982.91 1,334.22 109,698
Aflac Incorporated 59,258.80 17,164.00 3,646.00 12,716
Centene Corporation 33,361.58 198,101.00 -6,452.00 61,100
Cno Financial Group Inc 5,455.89 4,512.90 245.50 3,300
Futu Holdings Ltd 137,680.59 2,935.37 1,452.07 202
Molina Healthcare Inc 10,301.04 45,075.00 188.00 19,000
SUBTOTAL 1,952,439.38 2,981,795.07 73,885.55 1,843,932
14 more clients available

Sign in to see all corporate customers for Fresenius Medical Care Ag.

Sources: Fresenius Medical Care Ag’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Fresenius Medical Care Ag’s corporate clients.
For your research, we’ve provided 9 tables on Fresenius Medical Care Ag corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.